IRMD

Q: What is the price of iRadimed (IRMD) today?

The price of iRadimed (IRMD) today is US$ 72,41, with a variation of 45.29% compared to the last year. The price of iRadimed (IRMD) started the year trading around US$ 55,00 and today it is at US$ 72,41. Follow the real-time price chart, the historical price of iRadimed (IRMD), and stock data from Ibovespa and international markets.

Q: When does iRadimed (IRMD) pay dividends?

iRadimed (IRMD) distributed dividends in the last year,in the months of March, May and August totaling US$ 0,51. The Dividend Yield for the last 12 months is 0,92%.

Q: iRadimed (IRMD) is it worth it?

Currently, iRadimed (IRMD) is priced at US$ 72,41, with a P/E of 43,58%, representing a deviation of 40,34% from its historical average P/E. In the last year, the stock showed a variation of 45.29% in its price and distributed US$ 0,51 in dividends, resulting in a Dividend Yield of 0,92%. The total shareholder return was 45,29%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of iRadimed (IRMD)?

Investing in stocks of iRadimed (IRMD) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of iRadimed (IRMD) yield today?

The yield of iRadimed (IRMD) was 1,60% in the last month, 45,29% in the last year and 259,55% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,66 in dividends, um Dividend Yield de 0,92%.If you wanted to buy 100 stocks of iRadimed (IRMD) today, the total investment would be US$ 7.241,00, based on the current price of US$ 72,41.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 10.520,45In 5 years: US$ 26.035,02In 10 years: 20.812,81It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

iRadimed Corporation

Price

US$ 72,41

variation (12m)

45,29%

p/l

43,58

p/vp

9,88

DIVIDEND YIELD

0,92%

price IRMD

BVMF

IRMD

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of IRMD

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

1,60%

3 months

25,52%

1 year

45,29%

2 years

93,85%

5 years

259,55%

10 years

187,43%

real profitability

profitability minus inflation.

1 month

1,60%

3 months

25,06%

1 year

38,92%

2 years

76,93%

5 years

165,70%

10 years

72,09%

Indicators IRMD

check out the fundamentals of iRadimed shares

P/E

43,58

Sector: -1,17 Industry: 0,67

P/SALES RATIO (PSR)

11,69

Sector: 1,90 Industry: 0,82

P/BV

9,88

Sector: 2,15 Industry: 2,20

DIVIDEND YIELD (DY)

0,92%

Sector: - Industry: -

ROA

20,08%

Sector: -26,82% Industry: -12,54%

ROE

22,67%

Sector: -29,96% Industry: -43,78%

ROIC

45,66%

Sector: -411,72% Industry: -113,08%

NET MARGIN

26,82%

Sector: -27,32% Industry: -11,31%

GROSS MARGIN

77,17%

Sector: 43,14% Industry: 31,92%

OPERATING MARGIN

31,12%

Sector: -23,34% Industry: -8,67%

P/EBITDA

36,64

Sector: 0,01 Industry: 1,52

P/EBIT

37,56

Sector: -1,25 Industry: 1,30

P/ASSET

8,75

Sector: 1,24 Industry: 0,92

BVPS

7,25

Sector: 3,73 Industry: 5,78

EPS

1,64

Sector: -0,77 Industry: -0,15

EQUITY / ASSETS

0,89

Sector: 0,45 Industry: 0,28

CAGR REVENUES 5 YEARS

20,99%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

99,77%

Sector: - Industry: -

FAIR PRICE OF iRadimed ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 72,41

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-77,41%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

IRMD indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
LLY	54,24	40,79	75,21%	0,70%	US$ 748,47 B	25,91%
ISRG	57,10	8,59	15,04%	0,00%	US$ 154,22 B	28,29%
TMO	30,19	3,92	12,99%	0,31%	US$ 198,37 B	15,12%
SNY	7,45	1,45	19,52%	4,60%	US$ 117,87 B	22,40%
MDT	26,06	2,52	9,68%	2,23%	US$ 121,45 B	13,63%
CVS	18,05	1,27	7,05%	3,41%	US$ 98,62 B	1,40%
ABT	16,70	4,59	27,50%	1,73%	US$ 233,46 B	32,43%
NVS	17,46	6,02	34,49%	2,98%	US$ 253,30 B	25,52%
GSK	13,53	4,54	33,57%	3,78%	US$ 88,47 B	15,70%
BSX	49,83	6,23	12,51%	0,00%	US$ 141,21 B	14,65%
TMDX	35,64	11,47	32,18%	0,00%	US$ 3,65 B	17,65%
HCA	15,62	-80,14	-513,25%	0,68%	US$ 99,22 B	8,61%
DHR	46,00	2,77	6,02%	0,58%	US$ 144,91 B	13,04%
INMD	6,23	1,53	24,58%	0,00%	US$ 961,70 M	42,09%
IDXX	47,09	33,79	71,76%	0,00%	US$ 49,29 B	25,09%
FMS	20,90	0,95	4,56%	2,93%	US$ 15,74 B	3,48%
PHG	90,38	2,15	2,38%	3,24%	US$ 25,85 B	1,45%
HUM	20,59	1,85	8,97%	1,27%	US$ 33,79 B	1,30%
RMD	27,03	6,65	24,62%	0,81%	US$ 39,71 B	27,88%

comparison of IRMD with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History IRMD

current DY: 0,92%

5-year average DY: 2,36%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	18/08/2025	28/08/2025	0,17000000
Dividends	20/05/2025	30/05/2025	0,17000000
Dividends	24/02/2025	05/03/2025	0,17000000
Dividends	15/11/2024	25/11/2024	0,15000000
Dividends	20/08/2024	30/08/2024	0,15000000
Dividends	20/05/2024	30/05/2024	0,15000000
Dividends	22/12/2023	12/01/2024	0,15000000
Dividends	13/02/2023	21/02/2023	1,05000000
Dividends	17/02/2022	24/02/2022	1,00000000

ABOUT THE COMPANY iRadimed

iRadimed Corporation

Average user rating I10

4.0 (6 people)

Estados Unidos

33 years

Foundation: 1992

2014

Year of debut on the stock exchange - 11 years

110

Employees

The Company iRadimed Corporation (Estados Unidos), is listed on Nasdaq with a market value of $ 931,84 Milhões, having a net worth of $ 94,30 Milhões.

With a total of 110 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 79,72 Milhões, which generated a profit in the amount of $ 21,38 Milhões.

As for its main indicators, the Company has a P/E ratio of 43,58, a P/BV ratio of 9,88 and in the last 12 months the dividend yield of IRMD was at 0,92%.

The Company is traded internationally through the ticker IRMD.

Market value

US$ 931,84 Milhões

Net worth

US$ 94,30 Milhões

US$ 94.300.000,00

Assets

US$ 106,45 Milhões

US$ 106.450.000,00

Total Number of Shares

13,00 Milhões

13.000.000

Average Daily Trading Volume

US$ 54,92 Thousand

US$ 54.915,96

Sector

Health

Industry

Medical Supplies and Equipment

IRMD

IRMD revenue and profits

IRMD results

DRAG THE FRAME TO SEE MORE DATA

IRMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 78,44 22,65% (12M)

P/L

18,05

3,41%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 295,41 --14,34% (12M)

P/L

13,77

1,97%

ROE

14,37%

P/VP

1,98

CNC - Centene

US$ 36,36 --50,12% (12M)

P/L

16,24

0,00%

ROE

3,96%

P/VP

0,64

HUM - Humana

US$ 271,00 2,98% (12M)

P/L

20,59

1,27%

ROE

8,97%

P/VP

1,85

SNY - Sanofi

US$ 48,80 --7,21% (12M)

P/L

7,45

4,60%

ROE

19,52%

P/VP

1,45

HCA - HCA Healthcare

US$ 410,68 3,20% (12M)

P/L

15,62

0,68%

ROE

-513,25%

P/VP

-80,14

LLY - Eli Lilly

US$ 819,40 --9,59% (12M)

P/L

54,24

0,70%

ROE

75,21%

P/VP

40,79

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 78,44 22,65% (12 M)

P/L

18,05

3,41%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 295,41 --14,34% (12 M)

P/L

13,77

1,97%

ROE

14,37%

P/VP

1,98

CNC - Centene

US$ 36,36 --50,12% (12 M)

P/L

16,24

0,00%

ROE

3,96%

P/VP

0,64

HUM - Humana

US$ 271,00 2,98% (12 M)

P/L

20,59

1,27%

ROE

8,97%

P/VP

1,85

SNY - Sanofi

US$ 48,80 --7,21% (12 M)

P/L

7,45

4,60%

ROE

19,52%

P/VP

1,45

HCA - HCA Healthcare

US$ 410,68 3,20% (12 M)

P/L

15,62

0,68%

ROE

-513,25%

P/VP

-80,14

LLY - Eli Lilly

US$ 819,40 --9,59% (12 M)

P/L

54,24

0,70%

ROE

75,21%

P/VP

40,79

Frequently Asked Questions

What is the price of iRadimed (IRMD) today?

The price of iRadimed (IRMD) today is US$ 72,41, with a variation of 45.29% compared to the last year. The price of iRadimed (IRMD) started the year trading around US$ 55,00 and today it is at US$ 72,41. Follow the real-time price chart, the historical price of iRadimed (IRMD), and stock data from Ibovespa and international markets.

When does iRadimed (IRMD) pay dividends?

iRadimed (IRMD) distributed dividends in the last year,in the months of March, May and August totaling US$ 0,51. The Dividend Yield for the last 12 months is 0,92%.

iRadimed (IRMD) is it worth it?

Currently, iRadimed (IRMD) is priced at US$ 72,41, with a P/E of 43,58%, representing a deviation of 40,34% from its historical average P/E. In the last year, the stock showed a variation of 45.29% in its price and distributed US$ 0,51 in dividends, resulting in a Dividend Yield of 0,92%. The total shareholder return was 45,29%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of iRadimed (IRMD)?

Investing in stocks of iRadimed (IRMD) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of iRadimed (IRMD) yield today?

The yield of iRadimed (IRMD) was 1,60% in the last month, 45,29% in the last year and 259,55% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,66 in dividends, um Dividend Yield de 0,92%.

If you wanted to buy 100 stocks of iRadimed (IRMD) today, the total investment would be US$ 7.241,00, based on the current price of US$ 72,41.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 10.520,45
In 5 years: US$ 26.035,02
In 10 years: 20.812,81

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

IRMD

iRadimed Corporation

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of IRMD

check out the fundamentals of iRadimed shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,92%

5-year average DY: 2,36%

type

date with

payment date

value

ABOUT THE COMPANY iRadimed

iRadimed Corporation

Estados Unidos

33 years

2014

110

PROFIT X PRICE IRMD

IRMD results

IRMD cash flow

evolution of assets - IRMD

IRMD balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions